Vanguard PRIMECAP Core Inv (VPCCX)

26.56 +0.02  +0.08% Aug 6 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 26.56
Turnover Ratio 7.00%
1 Year Fund Level Flows -1.379B

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 3.15% 5.08% 93
3M 16.08% 17.16% 72
6M -6.77% -1.38% 88
YTD -4.87% 1.62% 88
1Y 8.58% 13.68% 78
3Y 8.57% 10.09% 73
5Y 10.41% 9.77% 49
10Y 13.27% 12.10% 31
15Y 9.99% 8.12% 3
20Y -- 5.95% --
As of Aug. 6, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 5.19% 5.19% 0.00%
Stock 94.81% 94.81% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 82.65%
North America 82.65%
Latin America 0.00%
Greater Europe 13.73%
United Kingdom 3.80%
Europe Developed 9.92%
Europe Emerging 0.02%
Africa/Middle East 0.00%
Greater Asia 3.62%
Japan 1.80%
Australasia 0.00%
Asia Developed 1.05%
Asia Emerging 0.78%
Market Classification
% Developed Markets 99.20%
% Emerging Markets 0.80%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.90%
Communication Services 6.38%
Consumer Cyclical 7.75%
Consumer Defensive 0.56%
Energy 1.20%
Financial Services 10.39%
Healthcare 30.64%
Industrials 14.93%
Real Estate 0.01%
Technology 27.24%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 45.12%
Large 32.90%
Medium 20.49%
Small 1.46%
Micro 0.03%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 24.89%
Large Cap Blend 31.11%
Large Cap Growth 22.39%
Mid Cap Value 11.76%
Mid Cap Blend 5.37%
Mid Cap Growth 3.02%
Small Cap Value 0.53%
Small Cap Blend 0.82%
Small Cap Growth 0.11%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
LLY Eli Lilly and Co 4.99% 152.47 -0.27%
AMGN Amgen Inc 4.01% 239.63 -0.79%
BIIB Biogen Inc 3.81% 301.73 +8.67%
AZN AstraZeneca PLC ADR 3.49% 55.30 -1.62%
LUV Southwest Airlines Co 3.40% 32.97 -0.15%
MSFT Microsoft Corp 3.26% 211.70 -2.15%
TXN Texas Instruments Inc 2.97% 132.79 -0.71%
JPM JPMorgan Chase & Co 2.81% 98.97 +1.78%
NVS Novartis AG ADR 2.09% 82.55 -1.03%
SIE Siemens AG 1.95% -- --
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to provide long-term capital appreciation. The fund invests in stocks that its advisor believes offer a good balance between reasonable valuations and attractive growth prospects relative to their peers. Stocks selected for the fund typically have earnings growth potential that, in the advisor's view, is not reflected in their current market prices. It can invest in stocks across all industry sectors and market capitalizations.
General
Security Type Mutual Fund
Oldest Share Symbol VPCCX
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Large Blend
Prospectus Objective Growth
Fund Owner Firm Name Vanguard
Benchmark Index
MSCI US Prime Market 750 GR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Alfred Mordecai 15.65 yrs
James Marchetti 5.51 yrs
Joel Fried 15.65 yrs
M. Ansari 12.59 yrs
Theo Kolokotrones 15.65 yrs

Net Fund Flows

1M -238.57M
3M -467.41M
6M -946.19M
YTD -1.049B
1Y -1.379B
3Y -2.334B
5Y -2.083B
10Y -3.147B
As of July 31, 2020

Risk Info

Beta (5Y) 1.033
Historical Sharpe Ratio (10Y) 0.8834
Historical Sortino (All) 0.6596
Daily Value at Risk (VaR) 1% (All) 3.63%
Monthly Value at Risk (VaR) 1% (All) 16.35%

Fundamentals

Dividend Yield TTM (8-6-20) 1.46%
30-Day SEC Yield (8-6-20) 1.00%
7-Day SEC Yield --
Weighted Average PE Ratio 13.75
Weighted Average Price to Sales Ratio 1.279
Weighted Average Price to Book Ratio 2.546
Weighted Median ROE 29.58%
Weighted Median ROA 9.82%
Forecasted Dividend Yield 2.43%
Forecasted PE Ratio 13.36
Forecasted Price to Sales Ratio 1.192
Forecasted Price to Book Ratio 2.443
Number of Holdings 147
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.40%
Forecasted Book Value Growth 2.76%
Forecasted Cash Flow Growth 10.04%
Forecasted Earnings Growth 10.06%
Forecasted Revenue Growth 6.39%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors No
Minimum Initial Investment 3000.00 USD
Minimum Subsequent Investment 1.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.45%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 12/9/2004
Termination Date
Last Annual Report Date 9/30/2019
Last Prospectus Date 1/31/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.